Doctor profile · Federal record
Dr. Binaya Shrestha, MD
Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · New York, NY
- NPI 1346343639
- Accepts Medicare
- 40 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3410-3418 Broadway, 2Nd Floor
New York, NY 10031
(212) 283-2099
fax (212) 234-2939 - Mailing address
-
356 Central Park Ave, Unit E-1
Scarsdale, NY 105831342
Credentials & registration
- NPI registered
- September 2006 — 20 yrs on file
- Profile last updated
- September 17, 2008
- Year of graduation
- 1986 — 40 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- New York #239631
- Medicaid
- NY #02093387
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1346343639. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
367
Distinct HCPCS
4
Medicare allowed
$33,928
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 135 | 68 | $105 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 113 | 68 | $148 | |
82947 |
Blood glucose (sugar) level | 106 | 68 | $4 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 13 | 13 | $195 |
In context: peer comparison
Among 92 peers in this city , average services per provider: 220. This provider delivers 1.7× the peer median.Open Payments
Industry payments received
All-time total
$35
Transactions
1
Manufacturers
1
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Medtronic, Inc. | 1 | $34.65 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,742
Patients
661
Total drug cost
$1,406,668
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Glipizide | Generic | 349 | 81 | $3,766 |
| Levothyroxine Sodium | Generic | 304 | 67 | $4,780 |
| Metformin Hcl | Generic | 266 | 84 | $2,818 |
| Jardiance (Empagliflozin) | Brand | 258 | 56 | $247,787 |
| Ozempic (Semaglutide) | Brand | 215 | 42 | $259,141 |
| Novolog Flexpen (Insulin Aspart) | Brand | 205 | 58 | $223,731 |
| Farxiga (Dapagliflozin Propanediol) | Brand | 196 | 38 | $140,908 |
| Januvia (Sitagliptin Phosphate) | Brand | 174 | 35 | $141,794 |
| Atorvastatin Calcium | Generic | 163 | 41 | $2,065 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 124 | 33 | $79,930 |
Frequently asked questions
What is Dr. Binaya Shrestha's medical specialty?
Dr. Binaya Shrestha practices Endocrinology, Diabetes & Metabolism Physician in New York, NY.
Where does Dr. Binaya Shrestha practice?
Dr. Binaya Shrestha practices at 3410-3418 Broadway, New York, NY 10031. Office phone: 2122832099.
What is Dr. Binaya Shrestha's NPI?
Dr. Binaya Shrestha's National Provider Identifier (NPI) is 1346343639, issued by NPPES.
Does Dr. Binaya Shrestha accept Medicare assignment?
Yes. Dr. Binaya Shrestha accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Binaya Shrestha commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Established patient office or other outpatient visit (HCPCS 99214); Blood glucose (sugar) level (HCPCS 82947). Source: CMS Medicare Physician & Other Practitioners file.